biotechstocktrader

Website

http://BiotechStockTrader.com

Last 50 Posts by biotechstocktrader:

• »AtheroNova (AHRO) Mentioned by Analyst in Life Sciences Report
  24 May 2013 in Biotech
  
• »Investors Begin To Realize RNA’s Potential
  21 May 2013 in Biotech
  
• »The Ohio State University Begins Animal Study to Support Vycor’s (VYCO) VBAS Technology
  20 May 2013 in Biotech
  
• »RXi Pharma (RXII) to Expand Investor Awareness to Jeffries Healthcare Conference
  20 May 2013 in Biotech
  
• »Arrayit (ARYC) Turns a Page with First Quarter Profit
  20 May 2013 in Biotech
  
• »Finding the Next Big Blockbuster Drug
  16 May 2013 in Biotech
  
• »RXi Pharma (RXII) Reports Steady Progress in Q1 2013
  15 May 2013 in Biotech
  
• »AtheroNova Receives Russia’s Approval for Phase I Clinical Trials
  09 May 2013 in Biotech
  
• »RXi Pharma (RXII) to Showcase RXI-109 at Key Conference
  09 May 2013 in Biotech
  
• »Cardium’s (CXM) Generx Published in April Issue of Molecular Therapy
  02 May 2013 in Biotech
  
• »Cardium (CXM) Expands Awareness of Excellagen® at Industry Conference
  30 Apr 2013 in Biotech
  
• »RXi Pharmaceuticals to Present Monday, May 6th at ARVO Annual Meeting
  30 Apr 2013 in Biotech
  
• »RXi Pharmaceuticals Announces Investor and Analyst Symposium
  29 Apr 2013 in Biotech
  
• »Griffin Securities Issues Update on RXi Pharmaceuticals (RXII)
  26 Apr 2013 in Biotech
  
• »RXi Pharmaceuticals: Realizing RNA’s Revolutionary Potential
  26 Apr 2013 in Biotech
  
• »Neuralstem And The National Football League Alumni Association Announce Initiative On Brain Injury Treatment
  24 Apr 2013 in Biotech
  
• »American Cryostem (CRYO) Goes International
  23 Apr 2013 in Biotech
  
• »RXi Pharma (RXII) Appoints Two New Board Members with Significant Industry Expertise
  22 Apr 2013 in Biotech
  
• »Adipose Derived Stem Cells Providing a Bridge to the Future of Regenerative Medicine
  18 Apr 2013 in Biotech
  
• »Aethlon Medical (AEMD) Note: New Government Contract, Resubmission of IDE to Treat Hepatitis C (HCV), Biothreat Legislation Signed into Law by President Obama
  17 Apr 2013 in Biotech
  
• »It’s Time to Re-Think the Clinical Approach to Battle Cholesterol and Atherosclerosis
  17 Apr 2013 in Biotech
  
• »AtheroNova (AHRO) Sets the Stage for Upcoming Clinical Trials with New Board Member
  15 Apr 2013 in Biotech
  
• »American Cryostem Exhibiting at Important Plastic Surgeon’s Conference
  12 Apr 2013 in Biotech
  
• »Athersys Recognized in Peer-Reviewed Journals as Stock Maintains Strong Upward Move
  12 Apr 2013 in Biotech
  
• »AtheroNova Names Veteran Cleveland Clinic Researcher to Advisory Board
  11 Apr 2013 in Biotech
  
• »Methes Energies Production Facility Showcased on ‘How It’s Made’ Biodiesel Segment
  09 Apr 2013 in Biotech
  
• »Analyst Believes AtheroNova Inc. (AHRO) Could See $2.00 per Share
  08 Apr 2013 in Biotech
  
• »InVivo Therapeutics Receives Humanitarian Use Device Designation for Spinal Cord Injury Treatment
  04 Apr 2013 in Biotech
  
• »Retrace and Rise, Athersys Back on the Move
  01 Apr 2013 in Biotech
  
• »Aastrom Biosciences Announces Strategic Change in Research and Development Programs
  27 Mar 2013 in Biotech
  
• »Shire to Acquire SARcode Bioscience, Expands Presence in Ophthalmology
  25 Mar 2013 in Biotech
  
• »Arrayit’s Leadership Position in the $21B Global Life Sciences Market
  21 Mar 2013 in Biotech
  
• »Regenerative Medicine Newsletter March 18 2013
  19 Mar 2013 in Biotech
  
• »International Stem Cell Corporation Announces Positive Results of Primate Parkinson’s Study
  19 Mar 2013 in Biotech
  
• »ALR Technologies Releases Video Demonstrating the Value of the Health-e-Connect Remote Diabetes Management Program to Employers
  19 Mar 2013 in Biotech
  
• »Athersys (ATHX) Advances Studies & Strengthens Balance Sheet in Q4 2012
  14 Mar 2013 in Biotech
  
• »Cardium (CXM) Expands To Go Brands® Line-Up with VitaRocks® Kids Vitamins
  13 Mar 2013 in Biotech
  
• »BioTime Appoints Stephen C. Farrell to Board of Directors
  12 Mar 2013 in Biotech
  
• »MediciNova on the move, share price jumping, best time to buy is coming
  11 Mar 2013 in Biotech
  
• »Cytori Appoints New Executive Vice President and Chief Medical Officer
  26 Feb 2013 in Biotech
  
• »New Ways to Target Atherosclerosis
  26 Feb 2013 in Biotech
  
• »AtheroNova (AHRO) Receives Buy Rating and $2.00 Price Target
  20 Feb 2013 in Biotech
  
• »Osiris Therapeutics Receives Title of European Orphan Drug Designation for Prochymal®
  19 Feb 2013 in Biotech
  
• »Arrayit’s Early Ovarian Cancer Diagnostic Could Save 12,000 Lives a Year
  19 Feb 2013 in Biotech
  
• »Rejuvenated Regenerative Medicine: Stem Cells and Athersys on the Rise
  15 Feb 2013 in Biotech
  
• »Regenerative Medicine Newsletter February 13 2013
  14 Feb 2013 in Biotech
  
• »Time to dump diluted shares of Trius — or double down?
  13 Feb 2013 in Biotech
  
• »StemCells, Inc. Announces First Patient Cohort Completion
  13 Feb 2013 in Biotech
  
• »Cardium’s (CXM) Excellagen® Receives American Podiatric Medical Association Seal of Approval
  12 Feb 2013 in Biotech
  
• »Athersys (ATHX) Jumps 55% YTD Amid Growing Investor Interest
  12 Feb 2013 in Biotech